Neuroprotective properties of a protein kinase inhibitor against ischaemia‐induced neuronal damage in rats and gerbils

S. Satoh(Asahi Chemical & Industry (Japan)), Hisashi Hidaka(Kitasato University), Masatoshi Shibuya(Tohoku University), Ichiro Ikegaki, Taku Asano(Amsterdam UMC Location University of Amsterdam), Yasuhíro Suzuki(Osaka City University)

British Journal of Pharmacology

August 1, 1996

10.1111/j.1476-5381.1996.tb15579.x

Cited by 72

Related Papers

Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

|Journal of Biological Chemistry|1990|1.5k

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

|The Lancet|2018|793

KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.

|Journal of Biological Chemistry|1990|625

N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

|Proceedings of the National Academy of Sciences|1981|586

Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.

|Journal of Biological Chemistry|1987|513